Cargando…

Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats

BACKGROUND: Integrins α(v)β(3) and α(v)β(5), both of which specifically recognize the Arg-Gly-Asp (RGD) motif, are overexpressed on many solid tumors and in tumor neovasculature. Thus, coupling the RGD motif to the liposomal surface for achieving active targeting can be a promising strategy for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhongya, Deng, Jiaxin, Zhao, Yan, Tao, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414220/ https://www.ncbi.nlm.nih.gov/pubmed/22888235 http://dx.doi.org/10.2147/IJN.S33541

Ejemplares similares

Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
por: Song, Zhiwang, et al.
Publicado: (2017)

Size‐Dependent Cellular Uptake of RGD Peptides
por: Kemker, Isabell, et al.
Publicado: (2019)

Targeted Delivery of FLT-Morpholino Using Cyclic RGD Peptide
por: Uehara, Hironori, et al.
Publicado: (2017)

Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells
por: Egorova, Anna, et al.
Publicado: (2022)

Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect
por: Liu, Hao, et al.
Publicado: (2022)

Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging
por: Shi, Jiyun, et al.
Publicado: (2016)

RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer
por: Feng, Chan, et al.
Publicado: (2015)

Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease
por: Liu, Jiaxin, et al.
Publicado: (2020)

Evaluation of (111)In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability
por: Shi, Jiyun, et al.
Publicado: (2011)

Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
por: Sun, Jiawei, et al.
Publicado: (2017)

Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
por: Zhu, Ren, et al.
Publicado: (2017)

Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
por: Sheikh, Afsana, et al.
Publicado: (2022)

Preparation of RGD-modified Long Circulating Liposome Loading Matrine, and its in vitro Anti-cancer Effects
por: Liu, Xiao-yan, et al.
Publicado: (2010)

The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
por: Wang, Yingzheng, et al.
Publicado: (2023)

Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
por: Zhou, Yang, et al.
Publicado: (2011)

Preparation of DSPE-PEG-cRGD Modified Cationic Liposomes for Delivery of OC-2 shRNA and The Antitumor Effects on Breast Cancer
por: Liu, Chunyan, et al.
Publicado: (2022)

Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells
por: Wen, Xianchun, et al.
Publicado: (2018)

RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect
por: Bardania, Hassan, et al.
Publicado: (2019)

Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes
por: Dicheva, Bilyana M., et al.
Publicado: (2015)

Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide
por: Li, Chong, et al.
Publicado: (2013)

Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide
por: Zhang, Qianyu, et al.
Publicado: (2016)

Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells
por: Chen, Cheng-Wei, et al.
Publicado: (2011)

RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy
por: Xu, Zichen, et al.
Publicado: (2023)

Cyclic RGD-conjugated Pluronic(®) blending system for active, targeted drug delivery
por: Lim, Chaemin, et al.
Publicado: (2018)

Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy
por: Ji, De, et al.
Publicado: (2020)

Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for in-situ thrombus of pulmonary arteriole of pulmonary hypertension
por: Li, Jingtao, et al.
Publicado: (2022)

Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides
por: Amin, Mohamadreza, et al.
Publicado: (2022)

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
por: Scherzinger-Laude, Karine, et al.
Publicado: (2013)

Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies
por: Tang, Zhongyuan, et al.
Publicado: (2019)

Enhanced Therapeutic Efficacy of iRGD-Conjugated Crosslinked Multilayer Liposomes for Drug Delivery
por: Liu, Yarong, et al.
Publicado: (2013)

Enhanced cellular uptake of maleimide-modified liposomes via thiol-mediated transport
por: Li, Tianshu, et al.
Publicado: (2014)

Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells
por: Nai, Jingxue, et al.
Publicado: (2021)

Preparation, cellular uptake and angiogenic suppression of shikonin-containing liposomes in vitro and in vivo
por: Xia, Hongmei, et al.
Publicado: (2013)

Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy
por: Peters, Tanja, et al.
Publicado: (2015)

Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles
por: Chu, Yongchao, et al.
Publicado: (2017)

Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation
por: Kang, Myung Joo, et al.
Publicado: (2013)

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
por: Xu, Hongfei, et al.
Publicado: (2021)

cRGD Urokinase Liposomes for Thrombolysis in Rat Model of Acute Pulmonary Microthromboembolism
por: Liang, Chunting, et al.
Publicado: (2022)

Comparison of cyclic RGD peptides for α(v)β(3) integrin detection in a rat model of myocardial infarction
por: Laitinen, Iina, et al.
Publicado: (2013)

Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake
por: Li, Xiuying, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eoaodneo46lcdtuatl77d7o4qc